Invesco Ltd. Lexicon Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 59,743 shares of LXRX stock, worth $93,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,743

Previous 49,818 19.92%

Holding current value

$93,796

Previous $119,000 15.97%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $15,284 - $22,628	9,925 Added 19.92%	59,743 $100,000
Q1 2024 May 14, 2024	SELL	$1.3 - $3.58 $14,773 - $40,683	-11,364 Reduced 18.57%	49,818 $119,000
Q4 2023 Feb 12, 2024	BUY	$1.0 - $1.53 $9,245 - $14,144	9,245 Added 17.8%	61,182 $93,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $12,529 - $27,540	11,820 Added 29.46%	51,937 $56,000
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.49 $1,838 - $2,983	-855 Reduced 2.09%	40,117 $91,000
Q1 2023 May 12, 2023	SELL	$1.99 - $2.68 $499 - $672	-251 Reduced 0.61%	40,972 $99,000
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $17,766 - $25,267	9,870 Added 31.48%	41,223 $78,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $5,490 - $9,706	2,830 Added 9.92%	31,353 $75,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $1,737 - $3,566	-1,326 Reduced 4.44%	28,523 $53,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $2,088 - $4,166	1,071 Added 3.72%	29,849 $62,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $3,905 - $6,314	1,025 Added 3.69%	28,778 $113,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $15,439 - $24,438	4,568 Added 19.7%	27,753 $133,000
Q2 2021 Aug 17, 2021	BUY	$4.12 - $5.87 $44,141 - $62,891	10,714 Added 85.91%	23,185 $106,000
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $70,217 - $185,008	-20,353 Reduced 62.01%	12,471 $73,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $9,762 - $34,123	9,298 Added 39.52%	32,824 $112,000
Q3 2020 Nov 16, 2020	BUY	$1.44 - $2.1 $131 - $191	91 Added 0.39%	23,526 $33,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $41,011 - $53,900	23,435 New	23,435 $47,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $183,708 - $244,143	-34,338 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $9,055 - $16,491	2,077 Added 6.44%	34,338 $191,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $198,405 - $339,063	32,261 New	32,261 $214,000

Others Institutions Holding LXRX

# of Institutions

131

Shares Held

240M

Call Options Held

617K

Put Options Held

286K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $296M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account